Cesra:
a modern company – with prospects!
Extensive development work, supreme quality and ultra-modern manufacturing methods ensuring consistently high standards have made Cesra an acknowledged specialist in the manufacture of phytopharmaceutical medicaments. In Cesra’s view the future actually belongs to phytopharmaceuticals – medicaments, that is to say, of plant origin.
Our company stays closely in touch with the people who recommend and use our products. We see ongoing dialogue as essential. Those who recommend or prescribe Cesra’s medicinal products live in the same tricky and unpredictable environment, in health policy terms, as the manufacturers of pharmaceuticals. Only by closing ranks and standing shoulder to shoulder can we continue what Cesra has been doing for more than 70 years – working to find the best way of helping sick people. So Cesra engages in intensive dialogue with those working in the field, about medical, pharmaceutical and health policy issues. Prescribing physicians, in their turn, can count on Cesra to deliver top-quality phytopharmaceuticals, as well as excellent service and further training.
A business area of steadily increasing importance for us is the export of our products. We have close trading relations with Poland and the Baltic countries, and similar business links are currently being built up in other countries. In the Far East, China has long been one of the most important countries for our exports.
Cesra’s ultra-modern production facilities are also in demand with other manufacturers who do not produce their own preparations. Here Cesra offers its services as a contract manufacturer.
The company’s policy is dedicated to furthering the work of a charitable foundation. The profits it makes are channelled into projects for the alleviation of human suffering caused by natural or man-made catastrophes. Cesra traditionally lives up to this social aspiration from its position as a ‘small but beautiful’ pharmaceutical manufacturer. Cesra is the producer of premium phytopharmaceuticals of the very highest quality, and this will continue to be so in future. Our corporate policy is aimed at healthy growth. Our range of products is constantly being rounded out and extended. There may be innovations, wherever it makes therapeutic sense. But the supreme priority for us remains quality and service.